In several types of carcinomas reduced expression or abnormal location of E-cadherin and the catenins have been observed, and the involvement of the E-cadherin–catenin system in suppressing cancer progression is well established (Bracke et al, 1996; Hirohashi, 1998; Behrens, 1999). Here, CDH1 is linked to cancer.